Related Experiment Video
Updated: May 7, 2026

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors
Published on: August 16, 2024
Function of SP1 in tumors and focused treatment approaches for immune evasion (Review)
Xin Wang1,2, Pingping Cui1,2, Yongqi Deng3
1School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong 261053, P.R. China.
Abstract:
Immune escape is a phenomenon in which tumor cells or infections evade detection and clearance by the host immune system in various ways. During an antitumor immune response, cells increase the concentration of pentameric stalk, which enhances antigen presentation and recognition by the immune system. It has been found that both increased and decreased levels of specificity protein 1 (SP1) control oncogenes, thereby influencing tumorigenesis and cancer development. Thus, elucidating the mechanism underlying the role of SP1 in tumors may help identify novel prognostic indicators. However, the immune escape mechanism involved in SP1 poses new challenges to diagnosis and treatment. The present review used a combination of analogies and summaries to explore the structure, function, regulatory mechanism and biological activity of SP1 in normal and cancer cells, and aimed to discuss the regulatory function of SP1 in different tumors, as well as the relevant association between SP1 and clinical diagnosis and treatment, which revealed the importance of SP1 in tumorigenesis and cancer development. The novelty of the present review lies in the identification of novel immune evasion mechanisms and immunotherapeutic techniques that provide new insights and approaches for a deeper understanding of the role of SP1 in malignant tumors.
Related Concept Videos
Abnormal Proliferation
The Tumor Microenvironment
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

